NANOG and neoplasm: Furthermore, MCL1 silencing reversed resistant phenotypes against the cognate CTLs of CT26-Nanog cells (Supplemental Figure 13 and Figure 5, C and D), suggesting a crucial role of MCL1 in the tumor-intrinsic CTL resistance induced by NANOG.